Bihui Cao

1.2k total citations · 1 hit paper
19 papers, 536 citations indexed

About

Bihui Cao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Bihui Cao has authored 19 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Bihui Cao's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (4 papers). Bihui Cao is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (4 papers). Bihui Cao collaborates with scholars based in China, United States and Macao. Bihui Cao's co-authors include Kangshun Zhu, Baoxia Liang, Shuo Yang, Wensou Huang, Yongjian Guo, Jingwen Zhou, Qi Zhao, Licong Liang, Mingyue Cai and Liteng Lin and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Bihui Cao

18 papers receiving 529 citations

Hit Papers

Transarterial Chemoembolization Combined With Lenvatinib ... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bihui Cao China 9 272 222 129 110 107 19 536
Changqing Xie United States 14 465 1.7× 183 0.8× 129 1.0× 116 1.1× 165 1.5× 48 745
Rikke Løvendahl Eefsen Denmark 11 375 1.4× 165 0.7× 179 1.4× 82 0.7× 158 1.5× 32 624
Xingxing Qi China 9 259 1.0× 165 0.7× 133 1.0× 35 0.3× 111 1.0× 11 466
Kazumi Fushimi Japan 12 324 1.2× 343 1.5× 230 1.8× 52 0.5× 116 1.1× 18 634
Fumitaka Arihara Japan 7 327 1.2× 319 1.4× 174 1.3× 95 0.9× 50 0.5× 13 555
Manami Shimomura Japan 15 360 1.3× 345 1.6× 160 1.2× 52 0.5× 328 3.1× 35 763
Hannah M. Schutz Netherlands 4 333 1.2× 296 1.3× 115 0.9× 90 0.8× 101 0.9× 6 491
Hidetoshi Nakagawa Japan 17 419 1.5× 529 2.4× 230 1.8× 39 0.4× 145 1.4× 35 853
Rekha Samuel United States 9 261 1.0× 196 0.9× 113 0.9× 67 0.6× 280 2.6× 9 706
Muyun Peng China 11 333 1.2× 145 0.7× 48 0.4× 270 2.5× 217 2.0× 34 710

Countries citing papers authored by Bihui Cao

Since Specialization
Citations

This map shows the geographic impact of Bihui Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bihui Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bihui Cao more than expected).

Fields of papers citing papers by Bihui Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bihui Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bihui Cao. The network helps show where Bihui Cao may publish in the future.

Co-authorship network of co-authors of Bihui Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Bihui Cao. A scholar is included among the top collaborators of Bihui Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bihui Cao. Bihui Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Chunying, Bihui Cao, Vo Van Giau, et al.. (2025). SUV39H1 maintains cancer stem cell chromatin state and properties in glioblastoma. JCI Insight. 10(5). 3 indexed citations
2.
Cao, Bihui, Manting Liu, Zecong Xiao, et al.. (2025). CV1-secreting sCAR-T cells potentiate the abscopal effect of microwave ablation in heterogeneous tumors. Cell Reports Medicine. 6(2). 101965–101965. 1 indexed citations
3.
Cao, Bihui, et al.. (2025). Killing the killers: Natural killer cell therapy targeting glioma stem cells in high-grade glioma. Molecular Therapy. 33(6). 2462–2478. 5 indexed citations
4.
Zhang, Yunsen, Bihui Cao, Xinxiang Fan, et al.. (2025). Enhanced antibody-mediated cellular cytotoxicity of germline-like anti-HER2 antibodies through a point mutation in complementarity-determining regions. The Journal of Immunology. 214(7). 1849–1859.
5.
Cai, Mingyue, Wensou Huang, Wei Liang, et al.. (2024). Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study. Liver International. 44(4). 920–930. 13 indexed citations
6.
Cao, Bihui, Qianqian Ni, Zhuxin Chen, et al.. (2024). Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma. Journal of Leukocyte Biology. 117(2). 9 indexed citations
7.
Li, Junping, Hui Lian, Shuo Yang, et al.. (2024). NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer. International Journal of Biological Sciences. 20(5). 1578–1601. 14 indexed citations
8.
Gan, Ziqi, Wei Wu, Xiaojiang Sun, et al.. (2024). Photothermal-Triggered Extracellular Matrix Clearance and Dendritic Cell Maturation for Enhanced Osteosarcoma Immunotherapy. ACS Applied Materials & Interfaces. 16(49). 67225–67234. 7 indexed citations
9.
10.
Li, Junping, Hong‐Ming Hu, Yuling Hu, et al.. (2023). Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer. Translational Oncology. 39. 101825–101825. 3 indexed citations
11.
Cai, Mingyue, Wensou Huang, Jingjun Huang, et al.. (2022). Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study. Frontiers in Immunology. 13. 117 indexed citations breakdown →
12.
Huang, Shuai, Bihui Cao, Jinling Zhang, et al.. (2021). Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential. Cell Death and Disease. 12(3). 237–237. 79 indexed citations
13.
Cao, Bihui, Baoxia Liang, Manting Liu, et al.. (2021). Feasibility and safety of fine positioning needle-mediated breathing control in CT-guided percutaneous puncture of small lung/liver nodules adjacent to diaphragm. Scientific Reports. 11(1). 3411–3411. 8 indexed citations
14.
Liu, Jie, Shuo Yang, Bihui Cao, et al.. (2021). Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes. Journal of Hematology & Oncology. 14(1). 21–21. 75 indexed citations
15.
Cao, Bihui, Manting Liu, Jingjun Huang, et al.. (2021). Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer. International Journal of Biological Sciences. 17(14). 3850–3861. 71 indexed citations
16.
Yang, Shuo, Bihui Cao, Guangyu Zhou, et al.. (2020). Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer. Frontiers in Pharmacology. 11. 1089–1089. 52 indexed citations
17.
Cao, Bihui, Manting Liu, Lu Wang, et al.. (2020). Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer. Biochemical and Biophysical Research Communications. 524(1). 96–102. 71 indexed citations
18.
Cao, Bihui, et al.. (2019). Quantitative evaluation of breast density using a dual‐energy technique on a digital breast tomosynthesis system. Journal of Applied Clinical Medical Physics. 20(6). 170–177. 1 indexed citations
19.
Lin, Wei‐Chan, et al.. (2017). Investigation of an optimized scanning protocol for the dentomaxillofacial region using 320-slice multidetector computed tomography. Dentomaxillofacial Radiology. 46(4). 20160395–20160395. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026